Indirab Vaccine

Indirab Vaccine is administered intramuscularly according to established immunization schedules, typically involving multiple doses to ensure adequate immune response. It is suitable for use in both pre-exposure prophylaxis for high-risk populations such as veterinarians, animal handlers, and travelers to endemic areas, and post-exposure treatment in conjunction with wound management and rabies immunoglobulin when indicated.

The vaccine is contraindicated in individuals with known hypersensitivity to any component of the formulation. Common adverse reactions may include mild local injection site reactions such as pain, redness, or swelling, and systemic effects like fever or headache. Indirab Vaccine should be stored and handled according to manufacturer guidelines to maintain potency and efficacy.

Healthcare professionals should assess patient history and exposure risk before administration.